gall bladder carcinoma
Showing 1 - 9 of 9
Cholangiocarcinoma, Gall Bladder Carcinoma Trial in Worldwide (Gemcitabine, Cisplatin, Capecitabine)
Active, not recruiting
- Cholangiocarcinoma
- Gall Bladder Carcinoma
- Gemcitabine
- +2 more
-
Bankstown, New South Wales, Australia
- +66 more
Jan 22, 2023
Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,
Recruiting
- Biliary Tract Cancer (CCA)
- +4 more
- Durvalumab
- +2 more
-
Frankfurt am Main, GermanyKrankenhaus Nordwest
Jun 23, 2022
RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY
Recruiting
- Bile Duct Neoplasms
- Gall Bladder Carcinoma
- Radio frequency ablation
-
Hyderabad, Telangana, IndiaAsian Institute of Gastroenterology
Apr 1, 2022
Completion Radical Cholecystectomy Determine Survival in
Completed
- Gall Bladder Carcinoma
- Survival
- Curative surgery
- (no location specified)
Nov 5, 2021
Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,
Active, not recruiting
- Cholangiocarcinoma
- +3 more
- Durvalumab
- +3 more
-
Hannover, GermanyMedizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021
Biliary Carcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Trial in Tampa (Cisplatin, Gemcitabine, Copanlisib)
Completed
- Biliary Carcinoma
- +3 more
- Cisplatin
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 3, 2021
Cholangiocarcinoma, Gall Bladder Carcinoma Trial in Tianjin (Gemcitabine, Capecitabine)
Recruiting
- Cholangiocarcinoma
- Gall Bladder Carcinoma
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute and Hospital
Dec 17, 2018
System of Biliary Malignancies Based on Special Disease Database
Unknown status
- Cholangiocarcinoma
- +2 more
-
Shanghai, Shanghai, ChinaZhaohui Tang
Apr 13, 2018